LinkedIn ( LNKD) estimates, target were boosted at Morgan Stanley. Shares are now seen reaching $210, according to Morgan Stanley. Estimates also upped, given higher marketing solutions growth. Overweight rating. Nokia ( NOK) estimates, target were cut at Canaccord. Shares are now seen reaching $3.50, according to Canaccord Genuity. Estimates also reduced, as the company is likely losing market share to Samsung. Hold rating. Monsanto ( MON) price target and earnings estimates through 2014 were increased at Citi. Soybeans should drive growth starting in 2014 and the accelerated buyback is also a catalyst, said Citigroup. Price target goes to $122. Monsanto estimates, target raised at Piper as the company is carrying a lot of momentum into the planting season. Overweight rating. New York Community Bancorp ( NYCB) estimates were reduced at Citi through 2014 to reflect a soft quarter. Lower pre-payments and margins are expected and the anticipated accretive merger is unlikely to happen, said Citigroup. Thermo Fisher ( TMO) price target increased to $87 at UBS. Industry commentary has been positive, top line momentum remains intact and productivity and capital deployment will benefit the company, said UBS. Valent ( VRX) price target and estimates were reduced given the introduction of a generic version of Zovirax Ointment, said UBS. Price target goes to $81. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.